Menu

Digit Ratio and Sex Hormones

Men and women may have different finger-length ratios as a result of different sex hormone exposure during early embryonic development.

Sep 6, 2011
Tia Ghose

PIZZODISEVO, FLICKR

The balance of sex hormones may explain why men have different finger-length proportions than women, according to a new study in the Proceedings of the National Academy of Sciences.

Women usually have an index finger that is longer than their ring finger, while the reverse is true in most men. Scientists have long suspected that sex hormones play a role in this difference, but until now, had no experimental evidence for such a mechanism.

University of Florida researchers examined the developing fingers in female and male mouse embryos. When they tweaked the levels of estrogen and testosterone the mice were exposed to in utero, the finger skeletal precursor cells divided at different rates. The fourth finger grew proportionally longer in response to additional testosterone, while estrogen made the second finger longer. The results suggest that digit length could be used as a marker for early prenatal exposure to sex hormones in humans, which has been linked to some diseases.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!